已发表论文

mtDNA 突变在 PCOS-IR 中的潜在作用:综述

 

Authors Dong XC , Liu C, Zhuo GC, Ding Y

Received 25 November 2022

Accepted for publication 9 January 2023

Published 25 January 2023 Volume 2023:16 Pages 139—149

DOI https://doi.org/10.2147/DMSO.S393960

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Prof. Dr. Juei-Tang Cheng

Abstract: Polycystic ovary syndrome (PCOS) is the most common heterogeneous endocrine disease that affecting females in reproductive age. Insulin resistance (IR), an important molecular basis for PCOS, accounts for at least 75% of women carrying this syndrome. Although there have been many studies on PCOS-IR, the detailed mechanisms are not fully understood. As essential hub for energy generation, mitochondria are critical to insulin secretion and normal function, whereas mutations in mitochondrial DNA (mtDNA) result in mitochondrial dysfunctions contributing to the pathophysiology of PCOS-IR via the regulation of balance of oxidative stress (OS), energy deficiency, or hormone metabolism. In the current review, we summarize the clinical and molecular features of PCOS-IR and discuss molecular mechanisms related to mtDNA mutations.
Keywords: PCOS-IR, mitochondrial dysfunction, mtDNA mutations